CA1052267A - Table formulation - Google Patents

Table formulation

Info

Publication number
CA1052267A
CA1052267A CA245,882A CA245882A CA1052267A CA 1052267 A CA1052267 A CA 1052267A CA 245882 A CA245882 A CA 245882A CA 1052267 A CA1052267 A CA 1052267A
Authority
CA
Canada
Prior art keywords
tablet
sulphonamide
particle size
tablet according
median diameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA245,882A
Other languages
English (en)
French (fr)
Inventor
Allan J. Torode
David Harden
John Spence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of CA1052267A publication Critical patent/CA1052267A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA245,882A 1975-02-13 1976-02-12 Table formulation Expired CA1052267A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6174/75A GB1533243A (en) 1975-02-13 1975-02-13 Tablet formulation

Publications (1)

Publication Number Publication Date
CA1052267A true CA1052267A (en) 1979-04-10

Family

ID=9809772

Family Applications (1)

Application Number Title Priority Date Filing Date
CA245,882A Expired CA1052267A (en) 1975-02-13 1976-02-12 Table formulation

Country Status (14)

Country Link
JP (1) JPS51106711A (xx)
BE (1) BE838507A (xx)
CA (1) CA1052267A (xx)
DE (1) DE2605656A1 (xx)
DK (1) DK57376A (xx)
FI (1) FI760340A (xx)
FR (1) FR2300550A1 (xx)
GB (1) GB1533243A (xx)
HU (1) HU171201B (xx)
IE (1) IE42952B1 (xx)
IL (1) IL49024A (xx)
NL (1) NL7601423A (xx)
SE (1) SE7601564L (xx)
ZA (1) ZA76829B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
ZA822995B (en) * 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1460302A (en) * 1973-05-23 1977-01-06 Wellcome Found Tablet formulation
GB1499672A (en) * 1974-02-14 1978-02-01 Wellcome Found Tablet formulation

Also Published As

Publication number Publication date
FI760340A (xx) 1976-08-14
JPS51106711A (xx) 1976-09-21
BE838507A (fr) 1976-08-12
ZA76829B (en) 1977-09-28
NL7601423A (nl) 1976-08-17
HU171201B (hu) 1977-11-28
DE2605656A1 (de) 1976-08-26
IL49024A (en) 1979-03-12
IL49024A0 (en) 1976-04-30
FR2300550A1 (fr) 1976-09-10
SE7601564L (sv) 1976-08-16
GB1533243A (en) 1978-11-22
AU1110876A (en) 1977-08-18
IE42952B1 (en) 1980-11-19
FR2300550B1 (xx) 1979-09-21
DK57376A (da) 1976-08-14
IE42952L (en) 1976-08-13

Similar Documents

Publication Publication Date Title
CA2116563C (en) Dry gel pharmaceutical composition
KR960009182B1 (ko) 제약정제, 제약과립 및 그의 제조방법
US4562024A (en) Process for preparing granulate containing poorly compressible medicinally active matter
US4209513A (en) Tablet formulation
US4664915A (en) Compressed and formed alkaline component suitable for use in buffered aspirin product
JP2939262B2 (ja) 製薬顆粒剤
JPH0393731A (ja) 放出時間調節型製剤
CA2000763C (en) Dispersable formulation
EP0605514A1 (en) PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE.
CA1117418A (en) Antacid tablet formulation
CA1052267A (en) Table formulation
US5087454A (en) Ibuprofen tablet
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
NO309925B1 (no) FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor
CA1216523A (en) Sustained-release product containing suloctidil
JP3884056B1 (ja) 口腔内速崩錠の製造方法
KR101421330B1 (ko) 붕괴정
JPH06321790A (ja) 速崩壊性生薬製剤
GB2124078A (en) Processes for preparing tablets by a modified wet-granulation technique
IL46629A (en) Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide
GB2067900A (en) Tablets containing trimethoprim, sulphamethoxazole and polyvinylpyrrolidone
JPH1067657A (ja) マルチプルユニット型持続性製剤
NZ200695A (en) Compressed and formed alkaline component for use in buffered aspirin product
JPS6328414B2 (xx)
Rubinstein et al. The effect of four tablet binders on the bioavailability of frusemide from 40MG tablets